Research Abstracts - GreenMedInfo

Aug 28, 2026 Kočvarová R, Azar S, Agranovich B, Abramovich I, Kirillov S, Nemirovski A, Baraghithy S, Plaschkes I, Merquiol E, Rouvinski A, Blum G, Hinden L, Tam J

British journal of pharmacology

Cannabidiol, Cannabigerol

Nonalcoholic fatty liver disease (NAFLD)

Hepatoprotective, Hypolipidemic

View abstract

In Vitro Study

Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells.

Aug 28, 2026 Park JH, Kim DY, Na HH, Kwon TH, Park JS, Oh YT, Kim KC

Free radical biology & medicine

Cannabigerol

Pancreatic Cancer

Apoptotic, Antiproliferative

View abstract

In Vitro Study

Cannabigerol Reduces Lipid Peroxidation Influencing Oxidative Stress and Inflammation Signaling Pathways in Melanocytes Exposed to UVA Radiation.

Aug 28, 2026 Jarocka-Karpowicz I, Gęgotek A, Žarković N, Maruška A, Skrzydlewska E

Frontiers in bioscience (Landmark edition)

Cannabigerol

Melanoma, Ultraviolet Radiation Induced Damage

Anti-Inflammatory Agents, Antioxidants, NF-kappaB Inhibitor, Nrf2 activation

View abstract

Animal Study

Cannabigerol (CBG) Modulates Neutrophil Activity and Ameliorates Rheumatoid Arthritis Pathogenesis.

Aug 28, 2026 Aswad M, Pechkovsky A, Hamza H, Louria-Hayon I

Pharmaceuticals (Basel, Switzerland)

Cannabigerol

Rheumatoid Arthritis

Anti-Inflammatory Agents, Interleukin-6 Downregulation, Interleukin-1 beta downregulation

View abstract

Animal Study

Cannabigerol Alleviates Obesity-Induced Mitochondrial Dysfunction by Cardiolipin Fatty Acid Remodeling.

Aug 28, 2026 Bielawiec P, Konstantynowicz-Nowicka K, Chabowski A, Harasim-Symbor E

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Cannabigerol

Obesity, Mitochondrial Dysfunction

Antioxidants

View abstract

Research Abstracts Database

Abstracts Starting with "C"

Curcumol Alleviates Ferroptosis in Metabolic-Associated Fatty Liver Disease by Inhibiting EGFR-Endoplasmic Reticulum Stress Axis.

Curcumol targets the ATG4B-PKM2-lactate signaling axis to reverse EMT and inhibit colorectal cancer liver metastasis.

Curcumol Induces G1 Phase Arrest in SK-Hep-1 Cells by Targeting SKP2-Mediated p27 Degradation.

Curcumol Ameliorates Diabetic Nephropathy by Inhibiting Podocyte Ferroptosis Through the xCT/GPX4 Pathway.

Curcumol alleviates acute pancreatitis by inhibiting RIPK1/RIPK3/MLKL pathway-mediated necroptosis: integrated bioinformatics, network pharmacology, molecular docking and dynamics simulations, and experimental validation.

Curcumol Inhibits the Invasion and Migration of Breast Cancer via miR-206/NCL/ERα36.

Curcumol Inhibits the Laminin-Facilitated Malignant Progression in Small-Cell Lung Cancer via Disrupting Laminin-Integrin β1 Interaction.

Curcumol Alleviates Obesity-Related Insulin Resistance and Inflammation in Skeletal Muscle via the SRC/PI3K/AKT Axis.

Curcumin and nanocurcumin attenuate ethanol-induced cognitive and oxidative impairments in male rats.

Curcumin in pancreatic cancer: A comprehensive review of anticancer mechanisms, EMT modulation, and clinical challenges.

Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/HO-1 and NF-κB signaling pathways.

Comparative Protective Effects of Melatonin and Apigenin Against Paclitaxel-Induced Testicular Injury in Rats: Oxidative Stress, DNA Damage, Apoptosis, and NF-κB Signaling.

Computed tomography-guided oxygen-ozone injection for the treatment of lumbar disc herniation complicated with lumbar spinal stenosis.

Clinical applications of artificial intelligence-driven nitric oxide: a bibliometric and scientific mapping analysis.

Comprehensive strategy of sonodynamic therapy and gas therapy on tumor treatment.

Cognitive impairment in chronic respiratory disease patients using long-term oxygen therapy: a narrative review.

Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology.

Cannabidiol enhances tamoxifen efficacy via CREB-mediated suppression of ERα signaling in ER-positive breast cancer cells.

Comparative Anti-Obesity Potential of Cannabigerol-Dominant Cannabis sativa L. Inflorescence Extracts via Differential Regulation of Lipid Metabolism in 3T3-L1 Cells.

Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.

Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells.

Cannabigerol Reduces Lipid Peroxidation Influencing Oxidative Stress and Inflammation Signaling Pathways in Melanocytes Exposed to UVA Radiation.

Cannabigerol (CBG) Modulates Neutrophil Activity and Ameliorates Rheumatoid Arthritis Pathogenesis.

Cannabigerol Alleviates Obesity-Induced Mitochondrial Dysfunction by Cardiolipin Fatty Acid Remodeling.